(Q42696550)

5 November 2017

Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease (English)

1 reference

5 November 2017

0 references

0 references

1 reference

1 reference

1 reference

1

David W Kimberlin

1 reference

5 November 2017

Edward P Acosta

2

1 reference

5 November 2017

Pablo J Sánchez

3

1 reference

5 November 2017

Sunil Sood

4

1 reference

5 November 2017

Vish Agrawal

5

1 reference

5 November 2017

James Homans

6

1 reference

5 November 2017

Richard F Jacobs

7

1 reference

5 November 2017

David Lang

8

1 reference

5 November 2017

Jose R Romero

9

1 reference

5 November 2017

Jill Griffin

10

1 reference

5 November 2017

Gretchen A Cloud

11

1 reference

5 November 2017

Fred D Lakeman

12

1 reference

5 November 2017

Richard J Whitley

13

1 reference

5 November 2017

National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

14

1 reference

5 November 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Journal of Infectious Diseases

5 November 2017

1 reference

5 November 2017

197

1 reference

5 November 2017

6

1 reference

5 November 2017

836-845

1 reference

New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection

5 November 2017

1 reference

Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection

21 January 2018

1 reference

Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection.

21 January 2018

1 reference

Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?

21 January 2018

1 reference

Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection

21 January 2018

1 reference

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

21 January 2018

1 reference

Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation

21 January 2018

1 reference

Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.

21 January 2018

1 reference

Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus

21 January 2018

1 reference

Cytomegalovirus in the perilymphatic fluid.

21 January 2018

1 reference

Detection of human cytomegalovirus DNA in perilymph of patients with sensorineural hearing loss using real-time PCR.

21 January 2018

1 reference

Detection of herpesvirus DNAs in perilymph obtained from patients with sensorineural hearing loss by real-time polymerase chain reaction.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/528376

1 reference

5 November 2017

1 reference